Lexington, KY, United States of America

Ashok J Chavan


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2001-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Ashok J Chavan

Introduction

Ashok J Chavan is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of drug delivery systems, particularly in the development of innovative therapies involving camptothecin drugs. With a total of 2 patents, his work has the potential to impact cancer treatment significantly.

Latest Patents

One of his latest patents is focused on "Oligonucleotide delivery systems for camptothecins." This invention stabilizes camptothecin drugs in their antitumor active lactone form by complexing them with oligonucleotides, including RNA or catalytic RNA. The oligonucleotide-camptothecin drug complex can be incorporated within a macromolecular assembly, utilizing both viral and non-viral oligonucleotide vectors. This innovation allows for a combination of gene therapy and camptothecin drug therapy. Another significant patent is for "Water-soluble derivatives of camptothecin/homocamptothecin." This invention provides camptothecin and homocamptothecin analogs and derivatives that incorporate alkylamine and polyalkylamine moieties, enhancing their solubility and therapeutic potential.

Career Highlights

Ashok J Chavan is affiliated with the University of Kentucky Research Foundation, where he continues to advance his research and innovations. His work is characterized by a commitment to improving drug delivery systems and enhancing the efficacy of cancer treatments.

Collaborations

Some of his notable coworkers include Thomas G Burke and Ayhan S Demir, who have collaborated with him on various research projects.

Conclusion

Ashok J Chavan's contributions to the field of drug delivery systems exemplify the innovative spirit of modern inventors. His patents reflect a dedication to improving cancer therapies and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…